1. Polymorphic drug metabolism;Relling;Clin. Pharm.,1989
2. The disposition of debrisoquine in hypertensive patients;Silas;Br. J. Clin. Pharmacol.,1978
3. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites;Chalon;Clin. Pharmacol. Ther.,2003
4. Polymorphism of carbon oxidation of drugs and clinical implications;Sloan;Br. Med. J.,1978
5. The cardiovascular effects of the antihypertensive drug debrisoquin: A contribution to the pharmacology of chronic treatment. II I. Absence of adrenergic degeneration after 8-week administration to dogs;Saner;J. Pharmacol. Exp. Ther.,1978